The Company’s breakthrough technology and related IP – compact high-performance permanent magnets – address the primary obstacles that exist in the current MRI market. These include the high cost of purchasing, operating and maintaining high-field MRI systems, the complexity of operating complicated MRI systems, safety-related issues, and the physical limitations placed on traditional MRI systems due to their active magnetic fields. Aspect Imaging’s M-Series compact MRI systems solve all of these issues as the systems are affordable to purchase, they are virtually maintenance-free and have virtually no external magnetic field so they can be placed in many locations in a hospital clinically and anywhere in a research lab. In addition, the systems were designed to be operated by researchers or technicians with no prior imaging or MRI experience. Because of this simplicity of operation, the power of MRI as a diagnostic standard in the pre-clinical market will now be available to be applied to complex biological questions in many research application areas including cancer research, neurobiology, obesity and diabetes, in vivo and ex vivo (ie. 3D histology) anatomical imaging. The system can leverage a variety of techniques including 2D, 3D and contrast agent acquisition and analysis in addition to participating easily in multi-modality applications and image co-registration.
In the medical market, Aspect Imaging has multiple medical programs underway including highly efficient just-in-place compact MRI, such as the FDA-cleared Wrist MRI System. Because the system is safe and requires no shielding, or specialty power cooling, the insights provided by these high-performance MRI systems can now be accessed by facilities and doctors in a broad range of fields that don’t have the budget or specialty staff to operate a full-body MRI scan.
In the pre-clinical research market, the M-series compact one-touch MRI systems enable a wide variety of in vivo applications and research models. The M-series systems are also used for providing 3D MR-based Histology to complement and direct pathology and histology-based analysis.
For advanced industrial markets, Aspect’s FlowScan platform provides unmatched real-time quantitative results for rheological applications in agricultural, food processing, biofuel and process control verticals. In addition, Aspect also produces a state-of-the-art NMR platform with the same benefts of the FlowScan system for inline and bench-top measurement and real-time analysis of liquid composition that is essential in crude oil, FCC and petrochemical production.